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ABSTRACT
Aim To describe educational inequalities in cancer
survival and to what extent these can be explained by
comorbidity and health behaviours (smoking, physical
activity and alcohol consumption).
Methods The GLOBE study sent postal questionnaires
to individuals in The Netherlands in 1991 resulting in
18 973 respondents (response 70%). Questions were
asked on education, health and health-related
behaviours. Participants were linked for cancer diagnosis
(1991–2008), comorbidity and survival (up to 2010)
with the population-based Eindhoven Cancer Registry;
1127 tumours were included in the analyses.
Results 5-year crude survival was best in highly
educated patients as compared with low educated
patients for all cancers combined: 49% versus 32% in
male subjects (log rank: p<0.0001), 65% versus 49% in
female subjects (p=0.0001). Compared with highly
educated, low educated prostate cancer patients had an
increased risk of death (HR 2.9 (95% CI 1.7 to 5.1),
adjusted for age, stage and year). No or inconsistent
associations between educational level and risk of death
were seen in multivariable analyses for breast, colon and
non-small cell lung cancer. Although survival in prostate
cancer patients was affected by comorbidities
(HR2_vs_0_comorbidities: 2.6 (1.5 to 4.4)), physical activity
(HRno/little_vs__moderate_physical__activity: 2.0 (1.2 to 3.4))
and smoking (HRcurrent_vs_never_smokers: 2.6 (1.0–6.8)),
these did not contribute to educational inequalities in
prostate cancer survival (HRlow_vs_high_education: 3.1 (1.6
to 5.8) with adjustment for comorbidity and lifestyle).
Conclusions Compared with low educated, highly
educated prostate cancer patients had better survival.
Although presence of comorbidities, physical activity
levels and smoking status affected survival from prostate
cancer, these did not contribute to educational
inequalities in survival. The role of other factors for
inequalities in cancer survival needs to be explored.
INTRODUCTION
Many studies report the highest cancer mortality
rates among those with low socioeconomic position
(SEP).1–4 This disadvantage may be the result of
higher cancer incidence in low SEP groups. Indeed,
people from lower socioeconomic strata have more
or less consistent excess risks for respiratory
cancers, cancers of the head and neck and upper
gastrointestinal tract, liver and cervix uteri.1 5–7
Risks for cancers of the colon, breast and ovary
and malignant melanoma are generally lower in
those with a low SEP,1 5–7 which are likely related
to socioeconomic differences in unhealthy beha-
viours. Part of the increased risks of developing
lung and breast cancer can be explained by
smoking, alcohol intake and physical activity.8
Recently, smoking was thought to explain 19% of
all new cancer cases in the UK, whereas deficient
intake of fruits and vegetables, occupational expo-
sures, overweight and obesity and infectious agents
explained 4%–7% of cancer incidence.9
Increased cancer mortality rates among people
with lower SEP may result from increased incidence
and poorer survival from cancer. Survival rates from
cancer are generally better for patients with high
SEP,4 5 10–12 which has been ascribed partly to lower
prevalence of other chronic diseases (comorbidities)
in high SEP cancer patients.13 14 The presence of
these comorbidities is affected by lifestyle (eg,
smoking is related to the occurrence of chronic
obstructive pulmonary disease (COPD) and cardio-
vascular disease), and lifestyle likely influences the
socioeconomic inequalities in cancer survival as well.
Because unhealthy behaviours are not necessarily
reflected in quantifiable comorbidity scores, lifestyle
may further explain socioeconomic inequalities in
cancer survival. Previous studies on this topic
reported small effects of smoking, physical activity
and alcohol consumption upon socioeconomic differ-
ences in survival from respiratory-related cancers,
colorectal cancers and all cancers combined in New
Zealand and Sweden.15 16 The explanatory role of
lifestyle in socioeconomic inequalities in cancer sur-
vival has not been studied for other cancers separately
nor the additional effect of comorbidities. The aim of
our study is to describe educational inequalities in
cancer survival and to what extent these inequalities
can be explained by comorbidity and lifestyle factors.
The prospective GLOBE study was designed to
investigate several explanations for socioeconomic
inequalities in health in The Netherlands. Linkage
of information from study participants to the
Eindhoven Cancer Registry enabled us to study
the presence of socioeconomic inequalities in
cancer survival and the contribution of three
cancer-related behavioural risk factors (alcohol con-
sumption, smoking and physical activity) and
comorbidities.
METHODS
Population
The prospective cohort, that is, the Dutch GLOBE
study, started in 1991, and aimed to investigate the
contribution of explanatory factors to socio-
economic inequalities in health. GLOBE is the
Dutch acronym for ‘Health and Living Conditions
of the Population of Eindhoven and Surroundings’.
A detailed description of the purpose and design of
the GLOBE study, and the main results after the
first 10 years are presented elsewhere.17 18 In short,
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in 1991 a postal questionnaire was sent to non-institutionalised
Dutch persons between 15 and 75 years of age, living in or near
the city of Eindhoven, to which 18 973 individuals responded
(70.1%). The questionnaire included measures of SEP, self-
reported health, health-related behaviour (eg, smoking, alcohol
consumption, physical activity), material circumstances
(housing, income), psychosocial characteristics (marital status,
vitality), healthcare utilisation and childhood circumstances.
Cancer survival
The population-based Eindhoven Cancer Registry has collected
data on new cancer patients since 1955 according to inter-
national guidelines.19 Trained registry personnel actively collects
data on diagnosis, staging and treatment. Stage was divided
according to Tumour Node Metastasis (TNM) classification at
the year of diagnosis, according to the fourth, fifth and sixth
International Union Against Cancer editions, as appropriate.20–
22 Pathological T, N and M stages were used; clinical stage was
used if pathological stage was missing. In prostate cancer, we
used the clinical stage. Clinical TNM stage was determined by
physical examination, imaging, endoscopy, biopsy, surgical
exploration and other relevant examinations. Pathological TNM
stage was based on the evidence acquired before treatment, sup-
plemented or modified by the additional evidence acquired
from surgery and from pathological examination.
The registry also records serious comorbidity at diagnosis
according to an adaptation of the list of Charlson and cowor-
kers.23 An overview of the comorbidities associated with the
various cancer sites in relation to SEP is given elsewhere.13
Since 1988, the registry has covered an area in the south-east
of The Netherlands with a population of over 2 million inhabi-
tants, including the area in which GLOBE participants resided.
Information on vital status of the patients was obtained from
the population registries network, which provides virtually com-
plete coverage of all deceased citizens of The Netherlands.
Follow-up was complete for cancer patients until 31 December
2009. Non-cancer patients who moved out of the area were lost
to follow-up. Data on cause of death were not available in this
study.
Questionnaire information from respondents and cancer
registry records were linked in a two-step procedure. First, a
combination of the respondent’s sex, date of birth and the first
two characters of his or her last name at birth were used as a
linking key. In a second step, uncertain matches were checked
by visual inspection of the Eindhoven Cancer Registry, using
identifiable data (such as initials, full last names and address).
We included patients diagnosed from 1991 to 2008. Patients
who indicated in the questionnaire that they had suffered from
‘malignant disease or cancer’ in the past were excluded from the
present study (n=70, mainly cancers of the breast, colon and
lung and basal cell carcinomas), as patients could have changed
to a more healthy lifestyle in response to their disease. Survival
rates are only shown if at least five patients were at risk of dying
per subgroup for any given time since diagnosis. We studied
four common cancers: patients with colon and non-small cell
lung cancer, male subjects with prostate cancer, and female sub-
jects with breast cancer. In the analyses of all cancers combined,
basal cell carcinomas were excluded since these have very low
lethality. Furthermore, in case a patient had more than one
tumour, we only included the first cancer.
Educational level
Educational level was indicated by the highest attained level of
education with students classified according to their current
training, using a closed question in the baseline questionnaire.
Four different groups were created: (1) primary school only;
(2) lower vocational school and lower secondary school; (3)
intermediate vocational school and intermediate/higher second-
ary school; and (4) higher vocational school and university. In
The Netherlands, educational level is recognised as a good indi-
cator of SEP.24 The highly educated group was used as the refer-
ence group.
Behavioural variables
Self-reported current smoking behaviour was categorised into
four groups: never, former smoker, current smoker and
unknown. On the basis of questions on the average number of
days per week that individuals used alcohol and the average
number of glasses consumed per day, individuals were cate-
gorised into five groups for alcohol consumption: total abstai-
ners; light; moderate; excessive; and unknown drinkers (for
details see25). Leisure physical activity was calculated from the
number of hours spent on gardening, cycling, walking and phys-
ical exercise (none or little; moderate; much; unknown, for
details see26).
Survival analyses
Crude survival analyses were performed using the Kaplan–
Meier method, and comparisons between groups assessed by
the log rank test. Cox proportional regression analyses were per-
formed to assess the effects of comorbidities and behavioural
variables on risk of death. We first adjusted for age categories
(0–59, 60–69 and 70 years and older), period of diagnosis
(1991–1996, 1997–2002 and 2003–2008) and stage at diagno-
sis. Subsequently we adjusted for presence of comorbidities,
categorised into: 0; 1; 2 or more; unknown. We additionally
added alcohol, physical activity and smoking, resulting in the
final model. The comparisons of models with different covari-
ates were tested with the likelihood ratio test.
RESULTS
Between 1991 and 2008, 2576 first primary tumours were diag-
nosed within the GLOBE population of 18 973 individuals
(table 1). The percentage of patients with a low educational
level varied considerably per tumour localisation; 41% of male
small cell lung cancer patients and 39% of female patients with
non-melanoma skin cancer or with unknown primary localisa-
tion only attended primary school, compared with 19% and
18% of the male and female melanoma patients. Survival was
best in patients with a high educational level, in both male and
female subjects (figure 1). Crude 5-year survival for all cancers
combined (ie, all cancers as presented in table 1) was 49% in
male subjects with high educational level compared with 32%
in low education (log rank: p<0.0001), and 65% and 49% in
female subjects (p=0.0001), respectively (see figure 1).
Subsequent analyses were only performed on patients with
known educational level and with breast (female subjects only,
n=356), colon (n=226), prostate (n=271) or non-small cell
lung cancer (n=274). These 1127 tumours were present in
1096 patients. In prostate cancer, patients with low educational
level had poorer survival (log rank: p=0.0002), while crude sur-
vival from colon cancer and non-small cell lung cancer was the
lowest in highly educated patients (figure 1, p=0.2 and 0.5,
respectively). Breast cancer survival was best in highly educated
women (5-year survival 87%) and poorest in low educated
women (69%, p=0.2).
No consistent socioeconomic patterns were present in mean
age or stage distribution of the cancer patients (data not shown).
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The prevalence of comorbidities was slightly higher among low
educated cancer patients (table 2). Furthermore, among the low
educated patients, a higher proportion smoked and did not
drink any alcohol. Levels of physical activity were the highest
among the highest educated. Crude survival from colon, pros-
tate and breast cancer was better among patients with no or, in
case of prostate and breast cancer, one comorbidity than with
two or more comorbidities, with 11% higher 3-year survival in
colon cancer patients with no comorbidities compared with
patients with two or more comorbidities (p value log rank test:
0.0015), 21% in prostate (p=0.0004) and 8% in breast cancer
(p=0.0012). Furthermore, crude survival was better in prostate
and breast cancer patients with high compared with low levels
of physical activity (31% higher in prostate (p=0.0167), 2% in
breast (p=0.0454)) (table 3). Among prostate and breast cancer
patients, survival was better for those with light or excessive
alcohol consumption than for total abstainers or moderate con-
sumers, although none of these associations were statistically
significant.
In multivariable models adjusting for age, year of diagnosis
and stage at diagnosis, risk of death in prostate cancer patients
was higher for those with low compared with high education,
although with wide CIs (HRlow_vs_high_educated 2.9 (95% CI 1.7
to 5.1) see table 4). Associations of education with risk of death
among breast, colon and non-small cell lung cancer patients
were inconsistent and non-significant after adjustment for age,
year of diagnosis and stage at diagnosis.
In multivariable models for prostate cancer as presented in
table 5, poor survival was predicted by presence of comorbid-
ities (HR2 or more vs no comorbidities: 2.6 (1.5 to 4.4)), low levels of
physical activity (HRno/little vs moderate physical activity: 2.0 (1.2 to
3.4)) and being a current smoker (HRcurrent vs never smokers: 2.6
(1.0 to 6.8)). The increased hazard of death in low educated
prostate cancer patients compared with the highly educated
patients (model A, HRlow_vs_high_educated: 2.9 (1.7 to 5.1), table
4) hardly changed by inclusion of comorbidities
(HRlow_vs_high_educated: 2.7 (1.6 to 4.8), table 5), lifestyle beha-
viours (HRlow_vs_high_educated: 3.0 (1.6 to 5.6)) or both in the
model (HRlow_vs_high_educated: 3.1 (1.6 to 5.8)). In contrast to
lifestyle behaviours, adding comorbidity to the model leads to a
significantly better fit of the data (likelihood ratio test model A
+comorbidity compared with model A: p<0.01).
Survival of colon, breast and non-small cell lung cancers was
not associated with educational level and associations remained
of similar magnitude after inclusion of comorbidities and/or life-
style behaviours in the multivariable models (see online supple-
mentary tables S1, S2, S3A, S3B and S4).
DISCUSSION
In this study, we investigated educational differences in cancer
survival and the contribution of comorbidity and lifestyle to
survival. In all cancers combined and prostate cancer patients
separately, those with high education had the best survival.
In contrast, risks of death were inconsistently or not related
to education in colon, breast and non-small cell lung cancer.
Although comorbidity and lifestyle behaviours predicted
death in prostate cancer patients, these could not explain
the increased risk of death in low educated prostate cancer
patients.
Our results confirm previous studies that also pointed to
better survival for patients with high SEP for prostate cancer,
while our findings are not in line with associations previously
reported for breast, colon and lung (which will be discussed
later).4 5 11 12 14 27 Not surprisingly, the difference between
high and low SEP in survival was limited for lung cancer, which
is rather lethal and the effects of comorbidities and lifestyle are
expected to be minor. Contrasting our expectations, crude sur-
vival was lower in highly educated non-small cell lung cancer
patients than in low educated, although not significantly. These
probably relate to differences in comorbidities and age, since
hazards of death were not significantly related to education in
the multivariable analyses.
The reasons for socioeconomic inequalities in cancer survival
are not exactly known yet, but differences in stage at diagnosis,
treatment and lifestyle-related factors such as physical activity,
obesity and dietary patterns have been proposed. Some previ-
ous studies took into account stage at diagnosis, which was
reported not to fully explain better survival in high SEP
patients with prostate (depending on age), breast (only in
screen-detected tumours) and in some studies on colorectal
cancer.4 11 14 27 We also observed a strong significant effect of
stage on survival, but it did not explain all of the educational
inequalities in prostate cancer survival. In addition, excluding
stage from the age and year adjusted model only little increased
the HR for low compared with high educated patients
Table 1 Percentage of patients by tumour site (10 most common
and basal cell carcinoma) and educational level, patients in the
longitudinal GLOBE study, Eindhoven, The Netherlands, diagnosed
1991–2008
Educational level
Total
1.
Low 2. 3.
4.
High
Other/
unknown
N % % % % %
Males
Oesophagus (including cardia
stomach)
46 20 48 11 17 4
Colon 127 20 29 28 19 3
Rectum 62 27 34 16 19 3
Non-small cell lung cancer 225 35 30 20 8 6
Small cell lung cancer 69 41 36 10 13 0
Skin, melanoma 52 19 25 21 35 0
Skin, non-melanoma (SCC*) 69 28 29 19 20 4
Prostate 286 25 26 21 23 5
Urinary bladder 107 32 22 24 20 3
Primary localisation unknown 46 33 22 22 17 7
Total (excluding basal cell
carcinoma)
1435 27 30 21 18 4
Skin, basal cell carcinoma 186 25 28 19 23 5
Females
Colon 115 32 40 10 7 10
Rectum 40 35 38 20 3 5
Pancreas 26 35 54 12 0 0
Non-small cell lung cancer 65 34 49 12 0 5
Skin, melanoma 38 18 58 18 5 0
Skin, non-melanoma (SCC) 44 39 48 7 2 5
Breast 371 26 51 15 5 4
Corpus uteri 60 37 48 7 8 0
Ovary 39 23 44 18 13 3
Primary localisation unknown 41 39 37 5 10 10
Total (excluding basal cell
carcinoma)
1141 31 47 13 5 5
Skin, basal cell carcinoma 161 25 45 21 2 7
*SCC, squamous cell carcinoma.
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(data not shown). Also unsurprisingly, age was strongly related
to survival.
In our analyses we furthermore adjusted for presence of
comorbidities at diagnosis, and investigated the additional
effects of alcohol consumption, physical activity and smoking
on educational inequalities in cancer survival. We assumed
that by adjusting for comorbidity we also adjusted partly for
lifestyle. Comparing the models with comorbidity, behaviour
and the final model shows that associations of lifestyle hardly
changed by inclusion of comorbidity and vice versa (see online
supplementary tables S1, S2, S3A, S3B and S4, likelihood ratio
test for all comparisons not significant). This may suggest that
comorbidities reflect high-risk behaviours well.
Previously we have shown that comorbidities explained some
of the socioeconomic variation in breast, colorectal and prostate
cancer survival.13 14 27 Although comorbidity was reported to
be a significant prognostic factor in cancer,28 it did not explain
the educational difference in prostate cancer survival in our
study. We expect this to result from the rather weak association
between education and comorbidities.
Furthermore, differences in treatment between socioeconomic
groups may contribute to the socioeconomic inequalities in
Figure 1 Crude survival from cancer by tumour site and sex, according to educational level, patients in the longitudinal GLOBE study, Eindhoven,
The Netherlands, diagnosed 1991–2008.
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cancer survival. Unfortunately, small numbers of patients receiv-
ing each therapeutic option hampered inclusion in multivariable
analyses. However, since we adjusted for clinical stage in our
analyses, and since treatment is related to stage (as we expect
patients with more advanced stages of cancer to receive other
types of treatment than those with less severe stages), additional
adjustment for treatment is not likely to substantially change
our results.
Few studies investigated the role of lifestyle in socioeconomic
inequalities in cancer survival. A Danish study showed that
comorbidity, and to a lesser extent lifestyle, were influencing the
socioeconomic variation in colorectal cancer survival, while
factors related to disease or treatment were not contributing to
the variation.29 Also smoking status prior cancer diagnosis was
an important predictive factor for socioeconomic variation in
cancer survival in Norwegian women, whereas in breast cancer
no association with smoking status, alcohol consumption, stage
or comorbidity was found.30 In men smoking and alcohol con-
sumption did not explain socioeconomic variation in Swedish
overall cancer survival.15 In New Zealand, socioeconomic vari-
ation in colorectal cancer survival could not be explained by
smoking status, alcohol intake and physical activity.16 Previously
the role of alcohol was suggested to substantially influence
socioeconomic inequalities in male cancer mortality (being the
product of incidence and survival) in some, but not other
European countries.31 The Netherlands was not taken into
account.
Other factors that could contribute to the better survival in
highly educated cancer patients are healthier lifestyle in general
(other than we could measure). Furthermore, those with high
SEP have generally better capacity to obtain, process and under-
stand health information and services (the so-called ‘health liter-
acy’).3 32 These socioeconomic differences in health literacy
could have contributed to better cancer survival among highly
educated prostate cancer patients.
For prostate cancer we stratified the analyses according to
tumour stage to unravel possible screening effects. Overall,
results were similar to the total group of prostate cancer
patients. Compared with those with advanced stage, effects of
smoking and physical activity were stronger in those with loca-
lised disease (see online supplementary table S3A and S3B).
Presence of comorbidities strongly affected risk of death in
those with advanced disease (≥2 compared with no comorbid-
ities: HR 4.8 (95% CI 1.7 to 13.8)).
Prostate cancer survival might have also been influenced by
the increased use of prostate specific antigen (PSA) tests, which
occurred mainly from 2000 onwards.33–35 It has been reported
that PSA testing occurs more often in male subjects with high
compared with low SEP.36 However, by adjusting for tumour
stage at diagnosis we aimed at taking at least part of these socio-
economic differences in staging into account.
Relatively small studies like GLOBE take a long time to
answer questions on socioeconomic inequalities in survival of
specific types of cancer. A systematic approach to study these
inequalities is important, and cancer registries could play an
important role in these studies.
Table 3 Crude survival according to number of comorbidities at
diagnosis and behaviours at baseline (1991) per tumour site in the
longitudinal GLOBE study, Eindhoven, The Netherlands
Colon
Non-small
cell lung Prostate Breast
Mean age at diagnosis 70.4 66.4 70.1 63.5
3-year
survival
(%)
1-year
survival
(%)
3-year
survival
(%)
3-year
survival
(%)
Comorbidities at diagnosis
None 69 41 85 88
1 53 49 84 86
2 or more 58 45 64 80
Unknown 68 55 83 87
Smoking
Never 62 * 81 87
Former 63 52 80 84
Current 58 45 76 87
Unknown * * 86 92
Alcohol
Total abstainers 64 45 69 83
Light 67 45 82 90
Moderate 54 38 79 80
Excessive 55 57 90 94
Unknown 50 63 67 88
Physical activity
None/little 80 47 57 88
Moderate 57 48 82 85
Much 57 38 88 90
Unknown 56 50 * 64
Includes patients with prostate, non-small cell lung, colon and breast cancer,
diagnosed 1991–2008.
*Less than five patients in this group; data not shown.
Table 2 Distribution of comorbidity at diagnosis and behaviours
at baseline (1991) by educational level in the longitudinal GLOBE
study, Eindhoven, The Netherlands, including patients with prostate,
non-small cell lung, colon and breast cancer, diagnosed 1991–2008
Educational level
1. Low 2. 3. 4. High
p Value*Number of tumours 330 (%) 443 (%) 219 (%) 135 (%)
Comorbidities
None 27 43 35 39 0.0006
1 26 26 29 27
2 or more 35 21 23 23
Unknown 12 10 13 11
Smoking
Never 25 24 18 13 <0.0001
Former 25 33 39 55
Current 46 41 41 33
Unknown 5 2 2 0
Alcohol
Total abstainers 37 21 11 8 <0.0001
Light 33 45 39 39
Moderate 12 19 32 42
Excessive 8 9 14 7
Unknown 11 6 4 4
Physical activity
None/little 21 19 15 11 <0.0001
Moderate 58 56 49 50
Much 14 23 32 37
Unknown 8 2 4 2
*p Values are from χ2 test.
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Our study findings might be influenced by several methodo-
logical limitations. We have excluded subjects with prevalent
cancer at baseline (ie, 1991) in order to eliminate possible selec-
tion effects. The validity of the self-reported prevalence of
cancer in the study population that filled in the 1991 question-
naire was checked, and some under-reporting was found among
those with a lower educational level.37 Furthermore, we
assumed that lifestyle prior to cancer diagnosis was indicative to
lifestyle after diagnosis. However, this can be debated as the
experience of cancer diagnosis and treatment may serve as a
critical cue for an individual to make positive health behaviour
changes.38 Also the small number of patients within each group,
which is reflected by the wide CIs, is a serious weakness of our
study. This may explain the rather unusual results for colon,
breast and non-small lung cancer survival, which was not asso-
ciated with education. Unfortunately, we were only able to cal-
culate overall survival, since no SEP-specific life tables were
available to estimate cancer specific survival according to SEP.
Reporting of smoking habits, alcohol consumption and physical
activity may be inaccurate and is often understated or overstated in
case of physical activity, although a recent study reported that this
was not true for nicotine consumption.39–41 Reporting on these
items may differ across the SEP groups, thereby introducing differ-
ential bias. This may dilute the effect of lifestyle and may (partly)
explain why lifestyle hardly affected the educational differences in
cancer survival.
A disadvantage of using education is that it better reflects SEP
in some age cohorts than in others.42 Those born before 1950
may not have attained the educational level that could be
expected based on their potential abilities. This effect is prob-
ably stronger for women. The effect of possible misclassification
of SEP by using educational level may explain why our results
are not in accordance with previous studies on SEP and cancer
survival and on the prevalence of comorbidities and SEP, which
explained part of the inequalities in cancer survival.13 14
Besides, it may also explain the rather uncommon finding of
relatively few highly educated women with breast cancer.
However, we previously reported no consistent pattern for
breast cancer incidence with SEP for all ages combined, but
high incidence rates in elderly women with low SEP.7 Because a
large proportion of the breast cancer patients in our study is
relatively old, it may explain higher breast cancer incidence rates
in women with low education.
Nevertheless, comparison of the educational level with fiscal
data on household income and value of housing43 shows a fair
correlation.
A strength of this study is that the follow-up of the original
sample on vital status has been nearly complete (99.8%).
Additionally, the completeness of the Eindhoven Cancer
Registry is expected to be at least 95%;44 thus, only few new
cancer cases diagnosed within the registration area would not be
included in the cancer registry. Furthermore, the area covered
by the Eindhoven Cancer Registry is much larger than the area
covered by the GLOBE study, so participants who moved
outside the area of the GLOBE study, but still within the area of
the Eindhoven Cancer Registry, could also be included in the
present study. Those moving outside the GLOBE study area
were in a previous study found to be mainly highly educated
individuals with few comorbidities and high levels of physical
activity, which might have influenced our results. However,
these were mostly young individuals who have a low chance of
developing cancer.45 Finally, the two-step linkage procedure
Table 4 Multivariable risk of death according to tumour site for cancer patients in the longitudinal GLOBE study, Eindhoven, The Netherlands,
diagnosed 1991–2008
Colon Non-small cell lung Prostate Breast
HR 95% CI HR 95% CI HR 95% CI HR 95% CI
Age
0–59 1.0 1.0 1.0 1.0
60–69 1.7 0.8 to 3.7 2.1 1.4 to 3.1 2.0 0.7 to 5.2 1.3 0.8 to 2.1
70+ 1.9 0.9 to 4.1 2.6 1.7 to 3.9 5.0 1.6 to 12.7 2.5 1.5 to 4.0
Sex
Female 1.0 0.6 to 1.4 1.0 0.7 to 1.4 – –
Male 1.0 1.0
Year of diagnosis
1991–1996 1.0 0.6 to 1.7 1.5 1.0 to 2.2 1.0 0.0 to 1.9 0.8 0.4 to 1.4
1997–2002 1.4 0.9 to 2.2 1.5 1.1 to 2.1 1.3 0.2 to 2.1 1.1 0.6 to 1.9
2003–2008 1.0 1.0 1.0 1.0
Stage
1 1.0 1.0 1.0 1.0
2 1.0 0.5 to 1.9 2.7 1.4 to 5.5 1.0 0.0 to 2.0 2.0 1.3 to 3.1
3 1.9 1.0 to 3.6 2.9 2.0 to 4.3 1.2 0.2 to 3.0 2.6 1.4 to 4.9
4 8.4 4.4 to 16.1 5.9 3.8 to 9.0 4.0 1.4 to 7.8 10.8 5.0 to 23.2
Unknown 20.7 7.7 to 56.1 1.3 0.8 to 2.1 4.4 1.5 to 11.3 1.1 0.2 to 8.4
Education
1. Low 1.1 0.6 to 1.9 0.8 0.5 to 1.3 2.9 1.7 to 5.1 1.5 0.5 to 4.4
2. 0.7 0.4 to 1.2 0.7 0.4 to 1.2 1.5 0.4 to 2.6 1.3 0.4 to 3.5
3. 0.7 0.3 to 1.2 0.8 0.5 to 1.5 1.6 0.5 to 3.0 1.4 0.5 to 4.3
4. High 1.0 1.0 1.0 1.0
Values in bold are significant. Models are adjusted for all variables listed.
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ascertained the appropriate identification of cancer patients
within the GLOBE cohort. This makes it unlikely that the
results have been biased by incompleteness of data on cancer
diagnosis.
To conclude, highly educated prostate cancer patients had
reduced risks of death. Although presence of comorbidities,
physical activity levels and smoking status affected survival from
prostate cancer, these did not explain educational inequalities in
prostate survival. The role of other factors, such as capacity to
obtain, process and understand health information and services,
and access to healthcare, needs to be explored.
What is already known on this subject?
▸ Cancer survival is generally better for patients with high
socioeconomic position, which has been ascribed partly to
lower prevalence of other chronic diseases (comorbidities)
and generally healthier lifestyle behaviours in patients with
high socioeconomic position. The combined effect of
comorbidities and lifestyle and cancer survival according to
socioeconomic position has not been studied before.
Table 5 Multivariable risk of death for prostate cancer patients in the longitudinal GLOBE study, Eindhoven, The Netherlands, diagnosed
1991–2008
Model A+comorbidity
Model A+lifestyle
behaviours
Model A+comorbidity
+lifestyle behaviours
HR 95% CI HR 95% CI HR 95% CI
Age
0–59 1.0 1.0 1.0
60–69 1.8 0.7 to 4.7 2.4 0.9 to 6.4 2.1 0.8 to 5.7
70+ 3.9 1.5 to 10.1 5.8 2.2 to 15.5 4.7 1.7 to 12.6
Year of diagnosis
1991–1996 1.4 0.7 to 2.6 1.0 0.5 to 1.7 1.3 0.7 to 2.4
1997–2002 1.3 0.8 to 2.2 1.2 0.7 to 2.1 1.3 0.8 to 2.2
2003–2008 1.0 1.0 1.0
Stage
1 1.0 1.0 1.0
2 1.4 0.7 to 2.8 0.9 0.5 to 1.9 1.3 0.6 to 2.6
3 1.6 0.6 to 4.2 0.9 0.4 to 2.3 1.3 0.5 to 3.3
4 6.0 2.9 to 12.1 3.7 1.9 to 7.3 5.4 2.6 to 11.1
Unknown 5.9 2.3 to 15.3 4.8 1.8 to 12.6 6.5 2.5 to 17.4
Education
1. Low 2.7 1.6 to 4.8 3.0 1.6 to 5.6 3.1 1.6 to 5.8
2. 1.4 0.8 to 2.5 1.4 0.8 to 2.5 1.4 0.8 to 2.6
3. 1.6 0.9 to 2.9 1.6 0.9 to 2.9 1.5 0.8 to 2.8
4. High 1.0 1.0 1.0
Comorbidities
0 1.0 1.0
1 1.5 0.9 to 2.5 1.8 1.0 to 3.0
2 or more 2.6 1.5 to 4.4 3.0 1.7 to 5.1
Unknown 1.2 0.6 to 2.5 1.8 0.8 to 3.7
Alcohol
Abstainer 0.9 0.5 to 2.0 0.9 0.4 to 1.9
Light 1.0 0.6 to 1.7 1.1 0.6 to 1.7
Moderate 1.0 1.0
Excessive 1.3 0.6 to 2.8 1.3 0.6 to 2.8
Unknown 1.6 0.6 to 4.0 1.7 0.7 to 4.4
Physical activity
No/little 2.0 1.2 to 3.4 1.9 1.1 to 3.4
Moderate 1.0 1.0
Much 1.0 0.6 to 1.5 1.1 0.7 to 1.8
Unknown 2.5 1.0 to 6.4 3.2 1.3 to 8.4
Smoking
Never 1.0 1.0
Former 2.5 1.0 to 6.7 2.5 0.9 to 6.7
Current 2.6 1.0 to 6.8 3.0 1.1 to 7.8
Unknown 0.8 0.2 to 4.2 0.6 0.1 to 3.1
Likelihood ratio test compared with model A p<0.01 p>0.05 p<0.005
Values in bold are significant. Models are adjusted for all variables listed.
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What does this study add?
▸ Educational inequalities in survival were observed in prostate
cancer, while no or inconsistent associations were found for
breast, colon and non-small cell lung cancer. Although those
with comorbidities, with no or little physical activity and
current smokers had increased risk of death, these did not
explain educational inequalities in prostate cancer survival.
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